Recent Quotes (30 days)

You have no recent quotes
chg | %

Victhom Human Bionics Inc.  

(Public, TSE:VHB)   Watch this stock  
Find more results for VHB
0.120
0.000 (0.00%)
Delayed:   3:51PM EST
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.12 - 0.12
52 week 0.12 - 0.12
Open 0.12
Vol. 0.00
Mkt cap 1.84M
P/E     -
Div/yield     -
EPS -0.20
Shares     -
Beta 0.94
Inst. own     -

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin -934.30% -884.39%
Operating margin -934.30% -884.39%
EBITD margin - -1054.10%
Return on average assets -20.33% -10.32%
Return on average equity -41.91% -1560.99%
Employees 74 -
CDP Score - -

Address

suite 204, 5365, Jean-Talon East
MONTREAL, QC H1S 3G2
Canada
+1-438-3805244 (Phone)
+1-438-3811530 (Fax)

Website links

Description

Victhom Human Bionics Inc. (Victhom) is engaged in discovering and developing bionic devices in the field of orthotics and prosthetics. The Company owns patents in the field of orthotics and prosthetics (O&P), including intellectual property used in the Power Knee. The Company�s Biotronix business developed the Power Knee, a motor-powered, artificially intelligent prosthesis for above-knee amputees product. For the Company�s Biotronix business, Victhom has a license agreement with Ossur, a medical device company, for the commercialization of its prosthesis, the Power Knee, and the development of other products using its Biotronix intellectual property. On June 16, 2011, the Company sold its 44.4% participation in Neurostream to its partner Otto Bock.